{
  "trial_id": "NCT01621178",
  "trial_group": "chronic kidney disease",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, Gender, Hemoglobin A1c (HbA1c), Type 2 diabetes duration, Current insulin use, Current oral antihyperglycemic medication use, Estimated glomerular filtration rate (eGFR), Body mass index (BMI), Systolic blood pressure, Diastolic blood pressure, History of cardiovascular conditions, History of pancreatitis, Serum calcitonin level, Family history of medullary C-cell hyperplasia or carcinoma, History of proliferative retinopathy",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex",
          "Gender"
        ],
        [
          "HbA1c",
          "Hemoglobin A1c (HbA1c)"
        ],
        [
          "BMI",
          "Body mass index (BMI)"
        ],
        [
          "Sitting systolic blood pressure",
          "Systolic blood pressure"
        ],
        [
          "Sitting diastolic blood pressure",
          "Diastolic blood pressure"
        ],
        [
          "eGFR measures",
          "Estimated glomerular filtration rate (eGFR)"
        ]
      ],
      "remaining_reference_features": [
        "Race",
        "Ethnicity",
        "Weight",
        "Total daily insulin dose",
        "Duration of Chronic kidney disease",
        "Urine albumin-to-creatinine ratio",
        "Angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use"
      ],
      "remaining_candidate_features": [
        "Type 2 diabetes duration",
        "Current insulin use",
        "Current oral antihyperglycemic medication use",
        "History of cardiovascular conditions",
        "History of pancreatitis",
        "Serum calcitonin level",
        "Family history of medullary C-cell hyperplasia or carcinoma",
        "History of proliferative retinopathy"
      ]
    },
    "processed-gen-response": "Age, Gender, Hemoglobin A1c (HbA1c), Type 2 diabetes duration, Current insulin use, Current oral antihyperglycemic medication use, Estimated glomerular filtration rate (eGFR), Body mass index (BMI), Systolic blood pressure, Diastolic blood pressure, History of cardiovascular conditions, History of pancreatitis, Serum calcitonin level, Family history of medullary C-cell hyperplasia or carcinoma, History of proliferative retinopathy"
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Sex, Race, Duration of diabetes, HbA1c, BMI, eGFR, Systolic blood pressure, Diastolic blood pressure, Insulin regimen, Total daily insulin dose, Use of oral antihyperglycemic medication, History of cardiovascular conditions, History of pancreatitis, Serum calcitonin, History of proliferative retinopathy",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex",
          "Sex"
        ],
        [
          "Race",
          "Race"
        ],
        [
          "HbA1c",
          "HbA1c"
        ],
        [
          "BMI",
          "BMI"
        ],
        [
          "eGFR measures",
          "eGFR"
        ],
        [
          "Sitting systolic blood pressure",
          "Systolic blood pressure"
        ],
        [
          "Sitting diastolic blood pressure",
          "Diastolic blood pressure"
        ],
        [
          "Total daily insulin dose",
          "Total daily insulin dose"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity",
        "Weight",
        "Duration of Chronic kidney disease",
        "Urine albumin-to-creatinine ratio",
        "Angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use"
      ],
      "remaining_candidate_features": [
        "Duration of diabetes",
        "Insulin regimen",
        "Use of oral antihyperglycemic medication",
        "History of cardiovascular conditions",
        "History of pancreatitis",
        "Serum calcitonin",
        "History of proliferative retinopathy"
      ]
    },
    "processed-gen-response": "Age, Sex, Race, Duration of diabetes, HbA1c, BMI, eGFR, Systolic blood pressure, Diastolic blood pressure, Insulin regimen, Total daily insulin dose, Use of oral antihyperglycemic medication, History of cardiovascular conditions, History of pancreatitis, Serum calcitonin, History of proliferative retinopathy"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Sex, Ethnic Origin, Diabetes duration, BMI, eGFR, HbA1c, Insulin regimen, Total daily insulin dose, Systolic Blood Pressure, Diastolic blood pressure, Total cholesterol, Smoking history, Diabetic retinopathy, Neuropathy, Antihypertensive drugs, Statin, Antiplatelet drugs.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex",
          "Sex"
        ],
        [
          "HbA1c",
          "HbA1c"
        ],
        [
          "BMI",
          "BMI"
        ],
        [
          "Sitting systolic blood pressure",
          "Systolic Blood Pressure"
        ],
        [
          "Sitting diastolic blood pressure",
          "Diastolic blood pressure"
        ],
        [
          "eGFR measures",
          "eGFR"
        ],
        [
          "Total daily insulin dose",
          "Total daily insulin dose"
        ]
      ],
      "remaining_reference_features": [
        "Race",
        "Ethnicity",
        "Weight",
        "Duration of Chronic kidney disease",
        "Urine albumin-to-creatinine ratio",
        "Angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use"
      ],
      "remaining_candidate_features": [
        "Ethnic Origin",
        "Diabetes duration",
        "Insulin regimen",
        "Total cholesterol",
        "Smoking history",
        "Diabetic retinopathy",
        "Neuropathy",
        "Antihypertensive drugs",
        "Statin",
        "Antiplatelet drugs"
      ]
    },
    "processed-gen-response": "Age, Sex, Ethnic Origin, Diabetes duration, BMI, eGFR, HbA1c, Insulin regimen, Total daily insulin dose, Systolic Blood Pressure, Diastolic blood pressure, Total cholesterol, Smoking history, Diabetic retinopathy, Neuropathy, Antihypertensive drugs, Statin, Antiplatelet drugs."
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, body mass index (BMI), hemoglobin A1c (HbA1c), estimated glomerular filtration rate (eGFR), systolic blood pressure, diastolic blood pressure, type 2 diabetes duration, insulin use, oral antihyperglycemic medication use.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex",
          "sex"
        ],
        [
          "HbA1c",
          "hemoglobin A1c (HbA1c)"
        ],
        [
          "BMI",
          "body mass index (BMI)"
        ],
        [
          "eGFR measures",
          "estimated glomerular filtration rate (eGFR)"
        ],
        [
          "Sitting systolic blood pressure",
          "systolic blood pressure"
        ],
        [
          "Sitting diastolic blood pressure",
          "diastolic blood pressure"
        ]
      ],
      "remaining_reference_features": [
        "Race",
        "Ethnicity",
        "Weight",
        "Total daily insulin dose",
        "Duration of Chronic kidney disease",
        "Urine albumin-to-creatinine ratio",
        "Angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use"
      ],
      "remaining_candidate_features": [
        "type 2 diabetes duration",
        "insulin use",
        "oral antihyperglycemic medication use."
      ]
    },
    "processed-gen-response": "Age, sex, body mass index (BMI), hemoglobin A1c (HbA1c), estimated glomerular filtration rate (eGFR), systolic blood pressure, diastolic blood pressure, type 2 diabetes duration, insulin use, oral antihyperglycemic medication use."
  }
}